Stegall, Mark D.

The Banff 2019 Kidney Meeting Report (I): Updates on and Clarification of Criteria for T Cell- and Antibody‐mediated Rejection

Loupy, A., Haas, M., Roufosse, C., Naesens, M., Adam, B., Afrouzian, M., Akalin, E., Alachkar, N., Bagnasco, S., Becker, J. U., et al. (2020) · American Journal of Transplantation

Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes

Cited by 834

Deep Learning-Based Histopathologic Assessment of Kidney Tissue

Hermsen, M., de Bel, T., den Boer, M., Steenbergen, E. J., Kers, J., Florquin, S., Roelofs, J. J. T. H., Stegall, M. D., Alexander, M. P., Smith, B. H., et al. (2019) · Journal of the American Society of Nephrology

AI in cancer detectionMedical Image Segmentation Techniques

Cited by 344

The use of GLP1R agonists for the treatment of type 2 diabetes in kidney transplant recipients

Kukla, A., Hill, J., Merzkani, M., Bentall, A., Lorenz, E. C., Park, W. D., D’Costa, M., Kudva, Y. C., Stegall, M. D., & Shah, P. (2020) · Transplantation Direct

Diabetes Treatment and ManagementRenal Transplantation Outcomes and Treatments

Cited by 73

Free Fatty Acid Storage in Human Visceral and Subcutaneous Adipose Tissue

Ali, A. H., Koutsari, C., Mundi, M., Stegall, M. D., Heimbach, J. K., Taler, S. J., Nygren, J., Thorell, A., Bogachus, L. D., Turcotte, L. P., et al. (2011) · Diabetes

Lipid metabolism and biosynthesisAdipose Tissue and Metabolism

Cited by 58